An estimated of 70% of
type-2 diabetes patients have NAFLD.

Why Liver health is important for Diabetes?

Non-alcoholic fatty liver disease (NAFLD) is highly prevalent in type 2 diabetes mellitus (T2DM), likely reflecting the frequent occurrence of obesity and insulin resistance in T2DM.

NAFLD is strongly associated with obesity and metabolic disturbances such as insulin resistance, type 2 diabetes mellitus, and dyslipidemia. Diabetes raises your risk of nonalcoholic fatty liver disease, a condition in which excess fat builds up in your liver. Research indicates that NAFLD may contribute to prediabetes and type 2 diabetes. Because the liver plays such an important role in regulating the body’s blood sugar, the buildup of fat in the vital organ makes it harder to control fasting glucose levels. It also makes the body more resistant to insulin, straining the pancreas and its beta cells and speeding up the arrival of type 2 diabetes.

Yet even though the majority of people with type 2 diabetes may have fatty livers, the condition remains mostly undiagnosed, because of its asymptomatic condition during early stages, lack of disease awareness and the hidden nature of the disease.

References: World Health Organization | World Diabetes Day | American Diabetes Association | Healthline Chalassani N., et al. Hepatology, 67: 328-357 | Aravind A., et al. Journal of Intelligent Learning Systems and Applications. 2020;12:31-49.| De Ledinghen V., et al. Hepatology 2020.72;1(Suppl):906A | Raskin M., et al. Hepatology 2020.72;1(Suppl):273A | Cohn B., et al. Hepatology 2020.72;1(Suppl):943A

Why LIVERFASt™ is the right choice?

  • High accuracy for cirrhosis in type 2 diabetics as in non-diabetics
  • Better accuracy than ultrasound-based TE
  • Reliable test results
  • Earlier detection of liver disease condition in type 2 diabetes patients

How to get LIVERFASt™?

Share the LIVERFASt™ Brochure with your physicians or contact us to speak to a physician

Also see: